drugset
drugset / Trial / NCT06482177

The COAT Trial: Cequa's Onset of Action Trial

NCT06482177 ↗

Phase 4 Completed 52 enrolled Research Insight LLC
NaSingle-groupOpen-labelTreatment

Summary

Cequa's Onset of Action Trial: an Investigation of CEQUA's Speed of Onset in Improving Ocular Surface Health in Dry Eye Patients

Timeline

Start
2023-10-12
Primary completion
2024-06-05
Completion
2024-06-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide — —

Indications

dry eye syndrome